References
- Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis.9(5), 565–572 (2003).
- WHO. Rotavirus vaccines. Epidemiol. Rec.82, 285–287 (2007).
- Lepage P. Rotavirus infection in Europe: time for effective prevention? Pediatr. Infect. Dis. J.25(Suppl. 1), S5–S6 (2006).
- Grimwood K, Huang Q, Cohet C et al. Rotavirus hospitalisation in New Zealand children under 3 years of age. J. Pediatr. Child Health42, 196–203 (2006).
- Milne RJ, Grimwood K. Budget impact and cost–effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Value Health12(6), 888–898 (2009).
- Tate J, Panozzo C, Payne D et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics124, 465–471 (2009).
- Grimwood K, Buttery JP. Clinical update: rotavirus gastroenteritis and its prevention. Lancet370(9584), 302–304 (2007).
- Grimwood K, Lambert S. Rotavirus vaccines. Opportunities and challenges. Hum. Vaccin.5, 57–69 (2009).
- Lambert S, Faux C, Hall L et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med. J. Aust.191, 157–160 (2009).
- Patel M, Pedreira C, De Oliveira LH et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA301(21), 2243–2251 (2009).
- Cunliffe N, Kirsten M, Madhi S et al. Efficacy of human rotavirus vaccine RIX4414 in Africa during the first year of life. Presented at: 27th Annual Meeting of the European Society for Paediatric Infectious Diseases. Brussels, Belgium, 9 June 2009.
- WHO. Rotavirus vaccination. Wkly Epidemiol. Rec.84, 232–236 (2009).
- Newall AT, Beutels P, Macartney K, Wood J, MacIntyre CR. The cost–effectiveness of rotavirus vaccination in Australia. Vaccine25(52), 8851–8860 (2007).
- Bilcke J, Beutels P. Reviewing the cost–effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources. PharmacoEconomics27(4), 281–297 (2009).
- Beutels P, Scuffham PA, MacIntyre CR. Funding of drugs: do vaccines warrant a different approach? Lancet Infect. Dis.8(11), 727–733 (2008).
- McKie J, Richardson J. The rule of rescue. Soc. Sci. Med.56(12), 2407–2419 (2003).
Websites
- Wikipedia – List of countries by GDP per capita. http://en.wikipedia.org/wiki/List_of_countries_by_GDP_(PPP)_per_capita
- Ministry of Health. www.moh.govt.nsf/indexmh/immunisation-schedule
- International Society for Pharmacoeconomics and Outcomes Research. www.ispor.org/PEguidelines
- WHO. Commission on Macroeconomics and Health of WHO: report on macroeconomics and health: investing in health for economic development. Geneva, Switzerland (2001). www.globalhealth.ie/information-archives/article/19